Evaluation of the Effectiveness of Tai Chi versus Brisk Walking in Reducing Cardiovascular Risk Factors: Protocol for a Ranomized Controlled Trial

Int J Environ Res Public Health. 2016 Jul 5;13(7):682. doi: 10.3390/ijerph13070682.

Abstract

Physical inactivity is one of the major modifiable lifestyle risk factors for cardiovascular disease (CVD). This protocol aims to evaluate the effectiveness of Tai Chi versus brisk walking in reducing CVD risk factors. This is a randomized controlled trial with three arms, namely, Tai Chi group, walking group, and control group. The Tai Chi group will receive Tai Chi training, which consists of two 60-min sessions each week for three months, and self-practice for 30 min every day. The walking group will perform brisk walking for 30 min every day. The control group will receive their usual care. 246 subjects with CVD risk factors will be recruited from two outpatient clinics. The primary outcome is blood pressure. Secondary outcomes include fasting blood for lipid profile, sugar and glycated haemoglobin (HbA1c); body mass index, waist circumference, body fat percentage; perceived stress level and quality of life. Data collections will be conducted at baseline, 3-month, 6-month and 9-month. Generalized estimating equations model will be used to compare the changes in outcomes across time between groups. It is expected that both the Tai Chi and walking groups could maintain better health and have improved quality of life, and that Tai Chi will be more effective than brisk walking in reducing CVD risk factors.

Keywords: Tai Chi; brisk walking; cardiovascular risk factors.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adipose Tissue
  • Blood Glucose / analysis
  • Blood Pressure
  • Body Mass Index
  • Cardiovascular Diseases / prevention & control*
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Lipids / blood
  • Male
  • Middle Aged
  • Quality of Life
  • Risk Factors
  • Tai Ji*
  • Waist Circumference
  • Walking*

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Lipids
  • hemoglobin A1c protein, human